Polymorphisms of the MDR1 gene in the Czech population

被引:0
作者
Pechandova, K. [1 ]
Buzkova, H. [1 ]
Slanar, O. [1 ]
Perlik, F. [1 ]
机构
[1] Charles Univ Prague, Fac Med 1, Dept Pharmacol, Clin Pharmacol Unit, Prague 12800 2, Czech Republic
关键词
P-glycoprotein; MDR1; polymorphisms; frequencies;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There exists a marked inter-individual variability of P-glycoprotein expression and activity, which can be of clinical importance due to the large number of drugs that are substrates for the transporter. Previously identified polymorphisms in the MDR1 gene belong to important factors causing this phenomenon. Our aim was to investigate the frequency of major functional SNPs of the MDR1 gene coding for P-glycoprotein in the Czech population. DNA was isolated from whole blood of 189 healthy, young and unrelated subjects (99 females and 90 males, aged from 23 to 28 years). The genotypes of polymorphic positions C3435T, G2677T/A, C1236T and T-76A were determined by PCR-RFLP. Observed allelic frequencies were 56.5%, 46.0%, 0.53%, 44.5% and 37.6% for the alleles 3435T, 2677T, 2677A, 1236T and -76A, respectively. We have found 64 subjects homozygous for 3435T, 42 for 2677T, 40 for 1236T and 31 for -76A alleles. The allelic distribution complies well with Hardy-Weinberg equilibrium. Allelic frequencies of functionally important MDR1 variants are in the Czech population similar to that of other Caucasian populations.
引用
收藏
页码:184 / 189
页数:6
相关论文
共 17 条
[1]   Frequency distribution of C3435T mutation in exon 26 of the MDR1 gene in a Spanish population [J].
Bernal, ML ;
Sinues, B ;
Fanlo, A ;
Mayayo, E .
THERAPEUTIC DRUG MONITORING, 2003, 25 (01) :107-111
[2]   Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects [J].
Cascorbi, I ;
Gerloff, T ;
Johne, A ;
Meisel, C ;
Hoffmeyer, S ;
Schwab, M ;
Schaeffeler, E ;
Eichelbaum, M ;
Brinkmann, U ;
Roots, I .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :169-174
[3]   CYP3A4 and MDR1 alleles in a Portuguese population [J].
Cavaco, I ;
Gil, JP ;
Gil-Berglund, E ;
Ribeiro, V .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (10) :1345-1350
[4]   Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients [J].
Chowbay, B ;
Cumaraswamy, S ;
Cheung, YB ;
Zhou, QY ;
Lee, EJD .
PHARMACOGENETICS, 2003, 13 (02) :89-95
[5]   Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population [J].
Gaikovitch, EA ;
Cascorbi, I ;
Mrozikiewicz, PM ;
Brockmöller, J ;
Frötschl, R ;
Köpke, K ;
Gerloff, T ;
Chernov, JN ;
Roots, I .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 59 (04) :303-312
[6]  
Goreva OB, 2004, B EXP BIOL MED+, V138, P404
[7]   Structure of the multidrug resistance P-glycoprotein [J].
Higgins, CF ;
Callaghan, R ;
Linton, KJ ;
Rosenberg, MF ;
Ford, RC .
SEMINARS IN CANCER BIOLOGY, 1997, 8 (03) :135-142
[8]   Functional polymorphisms of the human multidrug-resistance gene:: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo [J].
Hoffmeyer, S ;
Burk, O ;
von Richter, O ;
Arnold, HP ;
Brockmöller, J ;
Johne, A ;
Cascorbi, I ;
Gerloff, T ;
Roots, I ;
Eichelbaum, M ;
Brinkmann, U .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3473-3478
[9]  
Ishikawa Toshihisa, 2004, Drug Metab Pharmacokinet, V19, P1, DOI 10.2133/dmpk.19.1
[10]  
Jamroziak K, 2002, POL J PHARMACOL, V54, P495